儿童支气管肺炎治疗中两种抗生素联合应用的价值分析  

The Value Analysis of Two Kinds of Antibiotics in Treatment of Children With Bronchial Pneumonia

作　　者：侯淑萍[1] 

机构地区：[1]濮阳市油田总医院儿科,河南濮阳457001

出　　处：《中国卫生标准管理》2016年第17期92-93,共2页China Health Standard Management

摘　　要：目的：分析儿童支气管肺炎治疗中两种抗生素联合应用价值。方法选取我院2014年1月-2015年1月确诊的支气管肺炎患者60例，随机抽取，将其分为两组，其中对照组30例，采用头孢哌酮-舒巴坦治疗，观察组30例在对照组的基础上，增加阿奇霉素治疗，观察两组患者治疗效果，并评价其应用价值。结果经治疗，观察组总有效率为96.7%；对照组为80.0%；观察组总有效率和显效率要高于对照组，比较差异具有统计学意义（P＜0.05）。结论针对儿童支气管肺炎患者，应用头孢哌酮-舒巴坦联合阿奇霉素治疗，比单一的应用头孢哌酮-舒巴坦治疗效果显著，能有效改善患者治疗效果。Objective Analysis value of children with bronchial pneumonia treatment with two combined antibiotics.Methods Selected 60 cases of bronchial pneumonia patients in our hospital from January 2014 to January 2015 confirmed random sample be divided into two groups,a control group of 30 patients in the use of cefoperazone-sulbactam treatment,30 cases in observation group based on the control group in azithromycin therapy,therapeutic effects were observed two groups of patients,and to evaluate its value.ResultsAfter treatment,the observation group of total effective rate was 96.7%,the control group was 80.0%,the observation group total effective rate and effective rate were significantly higher,the difference was significant（P〈0.05）.Conclusion For patients with bronchial pneumonia in children, cefoperazone- sulbactam combined with azithromycin than a single application of cefoperazone-sulbactam has significant treatment effect,can effectively improve patient outcomes.

关 键 词：儿童支气管肺炎 抗生素 联合应用 价值 

分 类 号：R725.6[医药卫生—儿科]